Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Series A Preferred Stock	Preferred Stock Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2021			0
Beginning balance at Dec. 31, 2021	$ 478,047		$ 0	$ 42	$ 585,397	$ (282)	$ (107,110)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2021				41,817,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Fees incurred for registration filings	(76)		0		(76)
Stock-based compensation	11,372		$ 0		11,372
Stock option exercises (in shares)			0	154,504
Stock option exercises	301		$ 0		301
Stock issued - on vested RSAs (in shares)			0	500,597
Stock issued – on vested RSAs	1		$ 0	$ 1
Contingent consideration shares issued (in shares)				64,130
Contingent consideration shares issued	816				816
Foreign currency translation	(578)		0			(578)
Unrealized gain on available-for-sale securities	(40)					(40)
Net loss	(80,299)		$ 0				(80,299)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2022			0
Ending balance at Jun. 30, 2022	409,544		$ 0	$ 43	597,810	(900)	(187,409)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2022				42,536,734
Beginning balance, preferred stock, shares outstanding (in shares) at Mar. 31, 2022			0
Beginning balance at Mar. 31, 2022	476,075		$ 0	$ 42	591,002	(438)	(114,531)
Beginning balance, common stock, shares outstanding (in shares) at Mar. 31, 2022				42,331,082
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Fees incurred for registration filings	(24)		0		(24)
Stock-based compensation	5,973		$ 0		5,973
Stock option exercises (in shares)			0	24,571
Stock option exercises	43		$ 0		43
Stock issued - on vested RSAs (in shares)			0	116,951
Stock issued – on vested RSAs	1		$ 0	$ 1
Contingent consideration shares issued (in shares)				64,130
Contingent consideration shares issued	816				816
Foreign currency translation	(422)		0			(422)
Unrealized gain on available-for-sale securities	(40)					(40)
Net loss	(72,878)		$ 0				(72,878)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2022			0
Ending balance at Jun. 30, 2022	409,544		$ 0	$ 43	597,810	(900)	(187,409)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2022				42,536,734
Beginning balance, preferred stock, shares outstanding (in shares) at Dec. 31, 2022		0	0
Beginning balance at Dec. 31, 2022	$ 364,188		$ 0	$ 43	611,739	(679)	(246,915)
Beginning balance, common stock, shares outstanding (in shares) at Dec. 31, 2022	42,832,231			42,832,231
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 14,220		$ 0		14,220
Stock option exercises (in shares)			0	144,043
Stock option exercises	305		$ 0		305
Stock issued - on vested RSAs (in shares)			0	565,027
Stock issued – on vested RSAs			$ 0
Contingent consideration shares issued (in shares)				116,973
Contingent consideration shares issued	2,263				2,263
Settlement of Global Cooling escrow (in shares)				(216,024)
Settlement of Global Cooling escrow	(5,115)				(5,115)
Foreign currency translation	140		0			140
Unrealized gain on available-for-sale securities	40		0			40
Net loss	(23,913)		$ 0				(23,913)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2023		0	0
Ending balance at Jun. 30, 2023	$ 352,128		$ 0	$ 43	623,412	(499)	(270,828)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2023	43,442,250			43,442,250
Beginning balance, preferred stock, shares outstanding (in shares) at Mar. 31, 2023			0
Beginning balance at Mar. 31, 2023	$ 358,107		$ 0	$ 43	619,227	(534)	(260,629)
Beginning balance, common stock, shares outstanding (in shares) at Mar. 31, 2023				43,289,969
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,856		$ 0		6,856
Stock option exercises (in shares)			0	63,105
Stock option exercises	181		$ 0		181
Stock issued - on vested RSAs (in shares)			0	188,227
Stock issued – on vested RSAs			$ 0
Contingent consideration shares issued (in shares)				116,973
Contingent consideration shares issued	2,263				2,263
Settlement of Global Cooling escrow (in shares)				(216,024)
Settlement of Global Cooling escrow	(5,115)				(5,115)
Foreign currency translation	35		0			35
Unrealized gain on available-for-sale securities			0
Net loss	(10,199)		$ 0				(10,199)
Ending balance, preferred stock, shares outstanding (in shares) at Jun. 30, 2023		0	0
Ending balance at Jun. 30, 2023	$ 352,128		$ 0	$ 43	$ 623,412	$ (499)	$ (270,828)
Ending balance, common stock, shares outstanding (in shares) at Jun. 30, 2023	43,442,250			43,442,250